RNA-seq analysis using EGFR-mutant NSCLC xenografts also demonstrated the similar changes of TNF-α/NF-κB signaling pathway and EMT-related markers before and after treatment (Supplementary Fig. 16). This evidence concerns the gene EGFR and non-small cell lung carcinoma.